A pilot study (Phase I/II) testing the immunologic activity and safety of AGS-004, an autologous HIV immunotherapeutic, in HIV-infected adults on HAART: Trial results
A randomized, double blind, phase IIB study testing the efficacy and safety of AGS-004 on host control of HIV replication during analytical treatment interruption: Trial results
Counselling programme in combination with nicotine replacement therapy
Can valacylovir attenuate inflammation in ART-treated HIV-infected individuals with herpes simplex virus type 2? Trial results
Brain imaging to understand HIV-associated neurocognitive disorder and predict response to cognitive training
Role of extended-released niacin on immune activation in HIV-infected patients treated with antiretroviral therapy: a proof-of-concept study
HIV Stigma Reduction Intervention with African, Caribbean and Black Faith Communities in Ontario
Efficacy potential of an internet-based sleep program to improve sleep quality in people with HIV
BonE health in ageING Women: improvement or prevention of changes in bone mineral density by switching antiretroviral agents
Indigenous, participatory evaluation and assessment of a culturally-grounded and arts-informed intervention for HIV-positive Aboriginal women
Development of a psychosocial intervention trial with the goal to improve older adults’ ability to cope with HIV-Associated Neurocognitive Disorder (HAND)
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.v
Learn More